Keyholder Funding



Keyholder offers a portfolio of risk managed, potentially high return investments in a fast growing global market. Funds are used to complete late stage development, manufacture and commercialisation of treatments or diagnostics and bring to Big Pharma. It is a unique opportunity to fund major, cutting edge advances in the fight against cancer that will radically improve patient survival and the way cancer is treated.